Global Fluorescent Antibody Test (FAT) Market, By Technology (ELISA/Immunohistochemistry, Chromatography techniques, PCR, Others), Products (Instruments, Reagents and Kits, Accessories), Method (Direct, Indirect), Indication (Infectious Diseases, Autoimmune Diseases), Antigen (Bacteria, Virus), End-User (Diagnostic Centers, Hospitals, Clinics, Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
In recent years, several international healthcare organisations are establishing collaborations with healthcare entities to develop and commercialise novel detection assays to drive disease-fighting efforts. For example, the World Health Organization (WHO), in collaboration with other healthcare organisations such as provincial health authorities, is involved in the promotion of rabies control research efforts around the world. The WHO has also released a number of documents illustrating various aspects of a comprehensive disease control programme.
- Data Bridge Market Research analyses that the Fluorescent Antibody Test (FAT) market to grow at a CAGR of 7.3% during the forecast period. The rising prevalence of rabies in both animals and humans has had a direct impact on the growth of the fluorescent antibody test (FAT) market.
Market Definition
The fluorescent antibody test (FAT) is a method for diagnosing rabies in fresh or frozen brain tissues that is based on antigen detection and is recommended by the World Health Organization (WHO) and the World Organization for Animal Health (OIE). A reflected light fluorescence microscope is used to detect antigens.
Fluorescent Antibody Test (FAT) Market Dynamics
Drivers
-
Government support and rise in dog bites incidence
The rising occurrence of rabies as a result of dog bites, favourable government policies and laws, and rising funds for research and development are some of the factors that will propel the fluorescent antibody test (FAT) market during the forecast period.
The increase in the cost of operations as well planned strategies from players
Furthermore, rising non-profit research and development activities, as well as aggressive strategies by top players such as mergers, expansion, and collaboration for the development of new products and launches, are boosting market growth.
Opportunities
Furthermore, advancements in software technology extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Additionally, a high emphasis on streamlining imaging workflows will further expand the Fluorescent Antibody Test (FAT) market's growth rate in the future.
Restraints/Challenges
On the other hand, increasing costs associated with rabies diagnosis, as well as a lack of consumer awareness about advanced technologies, will act as a market restraint for the fluorescent antibody test (FAT) market during the forecast period.
This fluorescent antibody test (FAT) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Fluorescent Antibody Test (FAT) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- MyBioSource.com and BioNote, Inc. These businesses work with healthcare organisations to eliminate the disease through vaccination programmes. They provide diagnostic tools for mapping prevalence, tracking the impact of the Mass Drug Administration (MDA) programme, reducing MDA, and post-elimination surveillance.
- Some companies focus solely on product development for diagnostic purposes, while others only develop products for research purposes. Abbexa Ltd, for example, develops and markets products solely for research purposes.
Global Fluorescent Antibody Test (FAT) Market Scope
The fluorescent antibody test (FAT) market is segmented on the basis of technology, product, method, indication, antigen and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- ELISA/immunohistochemistry
- Chromatography techniques
- PCR
- Others
On the basis of technology, fluorescent antibody test (FAT) market is segmented into ELISA/immunohistochemistry, chromatography techniques, PCR and others.
Products
- Instruments
- Reagents And Kits
- Accessories.
On the basis of product, fluorescent antibody test (FAT) market is segmented into instruments, reagents and kits, accessories. Instruments have been further segmented into fluorescent analyser, fluorescent microscope, flow cytometry, cell sorting, thermal cycler and others. Reagents and kits have been further segmented into c. difficile testing, chlamydia testing, herpes family testing, respiratory family testing and enterovirus testing.
Method
- Direct
- Indirect
On the basis of method, fluorescent antibody test (FAT) market is segmented into direct and indirect.
Indication
- Infectious disease
- Autonomous disease
On the basis of indication, fluorescent antibody test (FAT) market is segmented into infectious diseases and autoimmune diseases.
Antigen
- Bacteria
- Virus
On the basis of antigen, fluorescent antibody test (FAT) market is segmented into bacteria and virus.
End User
- Healthcare Providers
- Healthcare Payers
- Pharmacies
- clinics
On the basis of level of interoperability, the Fluorescent Antibody Test (FAT) market is segmented into healthcare providers, healthcare payers and pharmacies. Healthcare providers segment is further divided into hospitals and clinics, long-term care centers, diagnostics and imaging centers and other healthcare providers.
Fluorescent Antibody Test (FAT) Market Regional Analysis/Insights
The Fluorescent Antibody Test (FAT) market is analysed and market size insights and trends are provided by country, technology, product, method, indication, antigen and end-user as referenced above.
The countries covered in the Fluorescent Antibody Test (FAT) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the fluorescent antibody test (FAT) market due to improved healthcare infrastructure, a growing geriatric population, and the occurrence of diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The fluorescent antibody test (FAT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for fluorescent antibody test (FAT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the fluorescent antibody test (FAT) market. The data is available for historic period 2010-2020.
Competitive Landscape and Fluorescent Antibody Test (FAT) Market Share Analysis
The fluorescent antibody test (FAT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to fluorescent antibody test (FAT) market.
Some of the major players operating in the fluorescent antibody test (FAT) market Quidel Corporation, BioTek Instruments, Inc., Thermo Fisher Scientific Inc., Dewinter Optical Inc, Leica Microsystems, PicoQuant GmbH, Carl Zeiss AG, Cole-Parmer Instrument Company, LLC., Esco Micro Pte Ltd., BR Technologies, Merck KGaA,, OLYMPUS CORPORATION, labome.com, among others.
SKU-
